Today’s AI Top Pick: MNRO
8/4/2026 · Highly Shorted Oversold screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live MNRO price forecast →
MNRO is the cleanest expression of this screen's thesis right now: a heavily-shorted, deeply oversold name where the multi-timeframe tape has flipped constructive and the fundamentals actually hold up. Every timeframe forecast is positive and rising with horizon — 1h fc_long +29.49%, 4h +39.82%, 1d +42.91%, 1wk +50.33% — and near_term_bullish is 0.8 with bullish_prob 1.0. Crucially, price is not extended: pos_in_21bar_range_pct sits at 14.88/6.42/14.40/14.15 across timeframes with dd_from_21bar_high in the −23% to −26% band. This is a mean-reversion setup at the bottom of the range, not a chase. The screen mechanics are potent here. Short float is 26.12% (top-quartile squeeze fuel), RSI 29.38 (deeply oversold), and perfYtd −36.38% means positioning is one-sided bearish. Unlike the higher-scored ADTN (weekly fc_long −8.7% — deteriorating trend) or PHAT (1wk fc_short −5.02% and fc_mid −1.84% — tape not confirming), MNRO has agreement across ALL four timeframes with magnitudes that grow into the mid/long horizons. That is exactly the multi-TF alignment the framework rewards. Fundamentals give it staying power vs the biotech lottery tickets in the pool. PEG 0.96, fwdPe 26.9, debtEq 0.91 (manageable), profit margin barely positive but real (0.59%), and analysts still constructive — Stephens maintained Overweight even while trimming PT to $17 (+31% from spot). Fund_score 2.5 is one of the better marks in the pool once you exclude names where the tape is broken (TGTX bullish_prob 0, forecasts all negative) or fundamentals are cratering. Why today, not wait: price is pinned near the 21-bar low across four timeframes, RSI is sub-30, and the near-term forecasts are already inflecting up (1h/4h leading). Waiting for a lower entry risks missing the squeeze reflex — with 26% short float and Stephens' $17 PT still in place, any positive tape action can force covering. The Q2 print is already digested (July 30 news), removing near-term event risk.
- Consumer cyclical weakness — salesYoY −4.98% and Q2 note flagged 'market pressures persist'; a soft macro print could re-trigger selling
- Stephens PT was just lowered to $17 on 7/30 and stock traded lower same day — sell-side momentum on estimates is still negative
- 26.12% short float cuts both ways: if the tape doesn't ignite, the pain trade continues down (no near-term catalyst until next print)
- PE 63 and fwdPe 26.9 are not cheap in absolute terms; multiple compression risk if EPS miss reappears
- Small-cap ($398M) with recom 2.2 — not a strong buy consensus, so no fast analyst rescue if it breaks $11.65
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | MNRO | BUY NOW | 8.4 | All four timeframes point up with growing magnitude, 26% short float, RSI 29, and price at the bottom of the 21-bar range — textbook squeeze setup with real fundamentals. |
| 2 | ACI | BUY NOW | 8.1 | Full multi-TF alignment plus a fresh CEO $450k open-market buy; only fundamentals (PE 153, debtEq 9.7) keep it from #1. |
| 3 | FIP | BUY PULLBACK | 7.2 | Best forecast magnitudes with near_term 1.0 and deep drawdown, but Q2 earnings today is a landmine — buy after the print if it holds $3.30. |
| 4 | ADTN | BUY PULLBACK | 6.3 | Best fund_score (5.75) and monster 1h/4h forecasts (+85/+56), but 1wk fc turns negative (−8.7%) and multiple PT cuts flag deteriorating trend. |
| 5 | PHAT | BUY PULLBACK | 6.0 | Strong 1h/4h/1d forecasts and salesYoY 110%, but 1wk fc_short −5% and fc_mid −1.8% shows the tape hasn't fully turned on the higher timeframe. |
| 6 | SPRY | BUY PULLBACK | 5.6 | All-timeframe positive forecasts (1d fc_long +93.6%, 1wk +88.6%) with deep drawdowns; new CEO transition is uncertainty, hence pullback entry. |
| 7 | VERA | BUY PULLBACK | 5.5 | Recent FDA approval for TRUTAKNA is a real positive, but 1h and 1wk forecasts are negative — wait for the tape to align. |
| 8 | WU | BUY PULLBACK | 5.3 | Cheapest name in the pool (PE 5.28, fwdPe 4.25) with multi-TF positive forecasts, but 1h at 99% of range means don't chase — buy a dip to $6.30. |
| 9 | METC | WAIT | 4.8 | RSI 26 and huge 4h/1d forecasts, but weekly still shows recent perf −32.7%, fwdPe 174, and Goldman just cut PT — coal cycle unclear. |
| 10 | NVAX | WAIT | 4.5 | 1h/4h/1d forecasts modest positive, but 1wk fc_long −75.8% is a red flag — the higher-timeframe tape says no. |
| 11 | BIRD | WAIT | 4.2 | Enormous short-horizon forecasts but 1wk fc_long −0.6% and fund_score −3; the pivot narrative is real but too early. |
| 12 | TDOC | WAIT | 4.0 | Mixed forecasts, 4h/1wk hint negative long, and Q2 note flagged 'cash pay decline and guidance pressure' — undercuts the setup. |
| 13 | NTLA | WAIT | 3.9 | 1h fc +36% is a single-bar outlier; Wolfe downgrade to Underperform with $9 PT and profit margin −597% argue against being early. |
| 14 | CAR | WAIT | 3.8 | All 1wk forecasts negative (fc_long −14.7%) and recom 3.44 is weakest in the pool — the tape doesn't confirm the screen. |
| 15 | WLK | WAIT | 3.7 | Only mildly oversold (dd −6.5%) and position 38–63% of range — not really at the bottom, doesn't match the setup type. |
| 16 | CMPX | WAIT | 3.6 | Big 4h/1d forecasts but 1wk fc_short −0.4% and salesYoY −100% — speculative regulatory play, not a screen-based buy. |
| 17 | BBNX | WAIT | 3.4 | 1h/1d forecasts negative, bullish_prob null; no confirming signal despite the screen match. |
| 18 | MBRX | AVOID | 3.0 | Micro-cap ($2M) with −82% 21-bar drawdown; the +550% forecasts are noise on illiquidity, not tradeable. |
| 19 | INO | AVOID | 2.8 | Just priced a $20M dilutive offering on 7/30 — the forecast is undercut by the equity raise landmine. |
| 20 | HTZ | AVOID | 2.5 | 52-week lows last week, roe −567%, profit margin −7.3%, and 1wk data missing from provided cutoff — broken tape. |
| 21 | TGTX | AVOID | 2.4 | Best fundamentals in the pool (fund_score 8) but bullish_prob 0 and every forecast negative (1wk fc_long −48.5%) — screen is a false positive here. |
| 22 | LESL | AVOID | 2.3 | Micro-cap ($10M) with −86% recent drawdown and 4h fc_long only +20% — the forecast can't rescue a broken chart. |
| 23 | BTCT | AVOID | 2.2 | $5M micro-cap with private placement dilution; forecast magnitudes are illiquidity artifacts. |
| 24 | QCLS | AVOID | 2.1 | Weekly forecast −100% and bullish_prob 0.2 — the higher timeframe says this is going to zero. |
| 25 | AESI | AVOID | 2.0 | Every timeframe forecast is negative or flat, expected_return −0.08%, and Q2 stock dropped on OK sales — no edge. |
| 26 | KPTI | AVOID | 1.8 | XPORT-EC-042 primary endpoint FAILURE on 7/31 and HC Wainwright downgrade — the forecast is fantasy vs a broken thesis. |
| 27 | SNBR | AVOID | 1.6 | −98% YTD, ps=0, 5000%+ forecasts are pure math noise on a sub-$3M market cap — untradeable. |
| 28 | BJDX | AVOID | 1.5 | $980k market cap; 5.4M% targetUpsidePct is data corruption, not a signal. |
| 29 | GDC | AVOID | 1.2 | Weekly recent −99.7% and 1wk fc all −100% — going to zero, screen is misleading here. |
| 30 | TC | AVOID | 1.0 | Chinese ADR with roe −1080%, profit margin −406%, no meaningful catalysts — pure junk. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord